The Worldwide Impact of the Seven-valent Pneumococcal Conjugate Vaccine

The Pediatric Infectious Disease Journal, 05/07/2012

Pneumococcal conjugate vaccines (PCV)–7 has shown dramatic reduction in disease and mortality rates in the countries in which it has been introduced. The newly introduced 10–valent and 13–valent pneumococcal vaccines are expected to have substantial disease impact, but monitoring is essential to determine their true impact and sustain further introduction of pneumococcal conjugate vaccines.

Print Article Summary Cat 2 CME Report